Phreesia, Inc. (NYSE:PHR) Shares Purchased by Nuveen Asset Management LLC

Nuveen Asset Management LLC lifted its holdings in shares of Phreesia, Inc. (NYSE:PHR - Free Report) by 77.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 235,827 shares of the company's stock after acquiring an additional 102,662 shares during the quarter. Nuveen Asset Management LLC owned 0.41% of Phreesia worth $5,933,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of PHR. Barclays PLC increased its position in shares of Phreesia by 83.6% during the third quarter. Barclays PLC now owns 94,929 shares of the company's stock worth $2,163,000 after acquiring an additional 43,225 shares during the last quarter. R Squared Ltd bought a new stake in Phreesia in the fourth quarter valued at about $30,000. Rhumbline Advisers increased its holdings in Phreesia by 7.4% in the fourth quarter. Rhumbline Advisers now owns 83,631 shares of the company's stock valued at $2,104,000 after buying an additional 5,756 shares during the last quarter. Venturi Wealth Management LLC bought a new stake in Phreesia in the fourth quarter valued at about $76,000. Finally, Peregrine Capital Management LLC increased its holdings in Phreesia by 0.8% in the fourth quarter. Peregrine Capital Management LLC now owns 319,327 shares of the company's stock valued at $8,034,000 after buying an additional 2,531 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on PHR. Wall Street Zen raised Phreesia from a "hold" rating to a "buy" rating in a report on Sunday. Truist Financial boosted their price objective on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. KeyCorp lowered their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. DA Davidson lowered their price objective on Phreesia from $36.00 to $34.00 and set a "buy" rating for the company in a report on Monday, April 14th. Finally, Citigroup reissued a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Twelve investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $31.64.

Phreesia Stock Performance

PHR stock traded down $0.54 during midday trading on Wednesday, reaching $25.24. The company had a trading volume of 393,591 shares, compared to its average volume of 439,359. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a 50 day moving average price of $24.72 and a 200 day moving average price of $25.36. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The firm has a market capitalization of $1.50 billion, a PE ratio of -17.17 and a beta of 0.74.

Phreesia (NYSE:PHR - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.06. The business had revenue of $115.94 million during the quarter, compared to the consensus estimate of $115.00 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business's revenue was up 14.5% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.05) earnings per share. Analysts anticipate that Phreesia, Inc. will post -1.1 earnings per share for the current year.

Insider Transactions at Phreesia

In other news, CFO Balaji Gandhi sold 1,827 shares of the business's stock in a transaction that occurred on Wednesday, March 26th. The stock was sold at an average price of $27.46, for a total transaction of $50,169.42. Following the completion of the transaction, the chief financial officer now directly owns 103,591 shares in the company, valued at approximately $2,844,608.86. The trade was a 1.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, General Counsel Allison C. Hoffman sold 3,496 shares of the business's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now owns 139,134 shares of the company's stock, valued at approximately $3,522,872.88. This represents a 2.45% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 42,474 shares of company stock worth $1,023,208. Company insiders own 5.50% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.